Recent News for CCCC - C4 Therapeutics, Inc.

Date	Title
May 22	We Think C4 Therapeutics (NASDAQ:CCCC) Can Afford To Drive Business Growth
May 10	C4 Therapeutics Inc (CCCC) Q1 2024 Earnings: Navigating Challenges with Strategic Collaborations
May 8	C4 Therapeutics GAAP EPS of -$0.41 in-line, revenue of $3.04M misses by $6.24M
May 8	C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights